CRA Senior Consultant Fiona Scott Morton testified in a successful verdict for a leading pharma company, Regeneron, in a Delaware court.
The jury awarded Regeneron $406 million, including $272 million in punitive damages, finding that the defendant, Amgen, bundled the sales of its cholesterol drug with two unrelated anti-inflammatory medications to pharmacy benefit managers. The jury agreed that the bundling practice foreclosed Regeneron’s rival drug. The CRA team supporting Professor Scott Morton was led by David Reitman, and included Javier Brugues Rodriguez, Stephen Kletter, Alessandro Kadner-Graziano, Alan Jaske, Charlie Hayman, Natsumi Osborn, and Andrew Pyper.
